CN1125107A

CN1125107A - Naoyujing medicine for curing traumatic intracranial hematoma

Info

Publication number: CN1125107A
Application number: CN 94113197
Authority: CN
Inventors: 蒋争鸣; 莫胜丹
Original assignee: Individual
Current assignee: Individual
Priority date: 1994-12-22
Filing date: 1994-12-22
Publication date: 1996-06-26

Abstract

The present invention relates to a proprietary Chinese medicine-Naoyujing for curing traumatic intracranial hematoma. Said proprietary Chinese medicine-Naoyujing is made up by using the Chinese medicines with the functions of supplementing qi and activating blood circulation by removing blood stasis, promoting blood clot dissolution and removing hematoma. ADVANTAGE-. Said product is low in cost, easy to take and has no toxic side-effect.

Description

A kind of Naoyujing medicine for the treatment of traumatic intracranial hematoma

The invention belongs to a kind of Naoyujing medicine for the treatment of traumatic intracranial hematoma of pharmaceuticals industry.

Traumatic intracranial hematoma accounts for about 10% in closed trauma of head, in Heavy craniocerebral injury, account for 40-50%, it is generally acknowledged that act last hematoma surpasses the 20-30 milliliter, curtain hematoma 10 milliliters down can produce symptom and need operation, conventional viewpoint: operation is the unique method of the acute intracranial hematoma of treatment.Do not having mainly to rely on mind before the CT, the variation of pupil determines whether operation.Occur having the patient of manifest symptom all to give operative treatment more than 20 milliliters to quantity of hematoma after the CT.Opening cranium removing hematoma is a bigger damage to patient, normal easy concurrent intracranial infection, brain abscess, osteomyelitis of cranium etc.Its sequela has: hemiplegia, aphasia, traumatic epilepsy, long-term stupor, defect of skull (needing operative repair once more), mental disorder, give patient's work, life, nursing bring serious social concern, bring very big burden for country, family and individual, and the danger of recurring hematoma in addition after the operation.So China and foreign countries' neurosurgeon is all for avoid the operative treatment effort as far as possible.

Adopting the visible in recent years minority report of western medicine intracranial hematoma, mainly is the mannitol dehydration therapy.This Therapeutic Method, dewatering time is long, dosage is big, and patient's body is disturbed greatly, particularly occurs the Water-Electrolyte disorder easily.The absorption of hematoma time is longer.Ningbo City's second hospital's neurosurgery is reported one group of 200 main intracranial hematoma patient's (" Zhejiang medical science " the 9th phase in 1992) who uses mannitol dehydration and dexamethasone treatment of example can support contrast.Transfer 5 examples of performing the operation in 200 examples.Develop into brain abscess 1 example, 7 examples of leaving hospital automatically because of prognosis is bad, dead 5 examples.CT check hematoma basic absorption has 56.1% in January, and checking in addition in March, 14.4% hematoma does not absorb.

The objective of the invention is to avoid above-described weak point, and provide a kind of dissolving of removing hematoma, promoting clot that has, a kind of Naoyujing medicine for the treatment of traumatic intracranial hematoma of effects such as absorption.

Compound method of the present invention: one, at first we select the product of benefiting qi and removing blood stasis for use, play the Chinese medicine batching of the merit of dissipation hematoma altogether, press the Radix Astragali 16～28%, Radix Codonopsis 4.0～7.0%, Rhizoma Chuanxiong 4.0～7.0%, the Rhizoma Atractylodis Macrocephalae 4.0～7.0%, Poria 4.0～7.0%, Radix Angelicae Sinensis 4.0～7.0%, the Radix Rehmanniae 4.0～7.0%, Typhonium flagelliforme (Lodd.) Blume 3.0～5.0%, Semen Persicae 3.5～7.0%, Flos Carthami 3.5～7.0%, Rhizoma Corydalis 3.5～7.0%, Pericarpium Citri Reticulatae 3.5～7.0%, Rhizoma Pinelliae Preparata 3.0～5.0%, Rhizoma Cimicifugae 2.5～3.5%, Radix Glycyrrhizae 2.5～3.5%, ratio is assorted; Two, pulverize: will assort Chinese medicine mixing pulverizing is No. 1 coarser powder; Three, boil and carry: get assort in the medicinal lifting manipulation of boiling get and carry three times, add 8 times of amounts of water for the first time, boiled 2 hours, second and third time adds 6 times of amounts of water, boils 1 hour.Three medicinal liquids of leaching are concentrated into about 8000ML; Be concentrated into 1: 1～2 concentration; Four, fill: get supernatant and bottle while hot.1 material of adding medicine to, dress 200ML, 40 bottles; Five, sterilization: the bottling rear pressing cover, the circulation steam sterilization got final product in 30 minutes.Utilize above Chinese medicine preparation can treat traumatic headache, the interior blood stasis symptom of postcerebral injury syndrome and human body etc.

Major advantage of the present invention: 1.Utilize Naoyujing medicine treatment traumatic intracranial hematoma simple and easy to do, the patient is easy to accept, and is without any side effects, can make about 1/3 traumatic intracranial hematoma patient exempt operation of opening cranium and the misery of the operation of holing, and saved the outer reason expense of surgery cost and postoperative; 2, Chinese medicine is also relatively more cheap, and each patient can save hospitalization cost, and preparation is simple, takes medicine conveniently, has the removing hematoma, promotes the dissolving of clot, the function of absorption; 3, it is sick that Naoyujing medicine also can be used for treating traumatic head, blood stasis symptom in postcerebral injury syndrome and the human body.

Most preferred embodiment of the present invention: get the Radix Astragali 24.8%, Radix Codonopsis 6.2%, Rhizoma Chuanxiong 6.2%, the Rhizoma Atractylodis Macrocephalae 6.2%, Poria 6.2%, Radix Angelicae Sinensis 6.2%, the Radix Rehmanniae 6.2%, Typhonium flagelliforme (Lodd.) Blume 4.1%, Semen Persicae 6.2%, Flos Carthami 6.2%, Rhizoma Corydalis 6.2%, Pericarpium Citri Reticulatae 6.2%, Rhizoma Pinelliae Preparata 4.1%, Rhizoma Cimicifugae 2.5%, the Chinese medicine ratio preparation of Radix Glycyrrhizae 2.5%, and by pulverizing, boil and propose the technology acquisition, boil and extract three times, add 8 times of amounts of water for the first time, boiled 2 hours, second and third time respectively adds 6 times of amounts of water, boiled 1 hour, three medicinal liquids of leaching are concentrated into 8000ML, are concentrated into 1: 1.65 concentration and get final product.

Claims

1, a kind of Naoyujing medicine for the treatment of traumatic intracranial hematoma, it is mainly by the Radix Astragali, Radix Codonopsis, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Angelicae Sinensis, the Radix Rehmanniae, Typhonium flagelliforme (Lodd.) Blume, Semen Persicae, Flos Carthami, Rhizoma Corydalis, Pericarpium Citri Reticulatae, Rhizoma Pinelliae Preparata, Rhizoma Cimicifugae, Chinese medicine of licorice root is prepared from, and the liquor strength during technology is boiled and carried is 8000ML, is concentrated into 1: 1～2 concentration.

2,, it is characterized in that it is the Radix Astragali 16～28% that Chinese medicine prepares ratio, Radix Codonopsis 4.0～7.0% according to right 1 described a kind of Naoyujing medicine for the treatment of traumatic intracranial hematoma, Rhizoma Chuanxiong 4.0～7.0%, the Rhizoma Atractylodis Macrocephalae 4.0～7.0%, Poria 4.0～7.0%, Radix Angelicae Sinensis 4.0～7.0%, the Radix Rehmanniae 4.0～7.0%, Typhonium flagelliforme (Lodd.) Blume 3.0～5.0%, Semen Persicae 3.5～7.0%, Flos Carthami 3.5～7.0%, Rhizoma Corydalis 3.5～7.0%, Pericarpium Citri Reticulatae 3.5～7.0%, Rhizoma Pinelliae Preparata 3.0～5.0%, Rhizoma Cimicifugae 2.5～3.5%, Radix Glycyrrhizae 2.5～3.5%.

3,, it is characterized in that the Naoyujing medicine of Chinese medicine preparation also can be treated traumatic headache, blood stasis symptom in postcerebral injury syndrome and the human body according to claim 1,2 described a kind of Naoyujing medicines for the treatment of traumatic intracranial hematoma.